![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Kamp, Marcel A.; Malzkorn, Bastian; Sass, Christiane von; DiMeco, Francesco; Hadjipanayis, Constantinos G.; Senft, Christian; Rapp, Marion; Gepfner-Tuma, Irina; Fountas, Konstantinos; Krieg, Sandro M.; Neukirchen, Martin; Florian, Ioan Stefan; Schnell, Oliver; Mijderwijk, Hendrik-Jan; Perin, Alessandro; Baumgarten, Peter; Lieshout, Jasper H. van; Thon, Niklas; Renovanz, Miriam; Kahlert, Ulf; Spoor, Jochem K. H.; Haenggi, Daniel; McLean, Aaron Lawson; Maeurer, Matthias; Sarrubbo, Silvio; Freyschlag, Christian F.; Schmidt, Nils O.; Vergani, Francesco; Jungk, Christine; Stein, Marco; Forster, Marie-Therese; Weinberg, Jeffrey S.; Sinclair, John; Belykh, Evgenii; Bello, Lorenzo; Mandonnet, Emmanuel; Moiyadi, Aliasgar und Sabel, Michael
(2021):
Proposed definition of competencies for surgical neuro-oncology training.
In: Journal of Neuro-Oncology, Bd. 153, Nr. 1: S. 121-131
2019
Herrlinger, Ulrich; Tzaridis, Theophilos; Mack, Frederic; Steinbach, Joachim Peter; Schlegel, Uwe; Sabel, Michael; Hau, Peter; Kortmann, Rolf-Dieter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Schnell, Oliver; Baehr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Kowalski, Thomas; Ringel, Florian; Schmidt-Graf, Friederike; Suchorska, Bogdana; Brehmer, Stefanie; Weyerbrock, Astrid; Renovanz, Miriam; Bullinger, Lars; Galldiks, Norbert; Vajkoczy, Peter; Misch, Martin; Vatter, Hartmut; Stuplich, Moritz; Schäfer, Niklas; Kebir, Sied; Weller, Johannes; Schaub, Christina; Stummer, Walter; Tonn, Jörg-Christian; Simon, Matthias; Keil, Vera C.; Nelles, Michael; Urbach, Horst; Coenen, Martin; Wick, Wolfgang; Weller, Michael; Fimmers, Rolf; Schmid, Matthias; Hattingen, Elke; Pietsch, Torsten; Coch, Christoph und Glas, Martin
(2019):
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
In: Lancet, Bd. 393, Nr. 10172: S. 678-688